2348.HK · DAWNRAYS PHARMA
Hong Kong · RS rating 61 · As of 2026-10-14
| Price | 0.99 HKD |
|---|---|
| 1-day change | +3.1% |
| RS rating (overall / 1M / 3M / 12M) | 61 / 66 / 60 / 52 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 28 / 15 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +20.8% |
| Market cap (USD) | $184.3M |